Loading clinical trials...

RECRUITING

A Registered Cohort Study on Charcot-Marie-Tooth Disease

A Registered Observational Cohort Study of Charcot-Marie-Tooth Disease

NCT04010188•Ning Wang, MD., PhD.

Summary

The aim of the study is to analyze the natural history data data from Charcot-Marie-Tooth disease and related disorders in China, to assess the clinical, genetic, epigenetic features of patients with Charcot-Marie-Tooth disease, and to optimize clinical management.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Patients with the clinical diagnosis of Charcot-Marie-Tooth disease
•Genetic diagnosis of patients with Charcot-Marie-Tooth disease
•Unrelated healthy controls

Exclusion Criteria

•Decline to participate.
•Other peripheral neuropathy caused by trauma, immunity and toxicosis.

Locations (1)

First Affiliated Hospital of Fujian Medical University

Fuzhou, China

Key Dates

Start Date

July 1, 2019

Primary Completion Date

December 31, 2039

Completion Date

December 31, 2049

Last Updated

January 11, 2022

Enrollment

500

ESTIMATED participants

Conditions

Charcot-Marie-Tooth Disease

Contacts

Ning Wang, MD, PhD

CONTACT

13805015340 ningwang@fjmu.edu.cn

Longitudinal Biomarkers With Selected Outcome Measures In CMT

NCT06794489

CMT1ACMT (Charcot Marie Tooth Disease)+2 more

View study

RECRUITINGNA

Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease

NCT07049588

Charcot-Marie-Tooth Disease Type 1A

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 11, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Registered Cohort Study on Charcot-Marie-Tooth Disease

Inclusion Criteria

Exclusion Criteria

Longitudinal Biomarkers With Selected Outcome Measures In CMT

Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease

High-Tech Rehabilitation Pathway for Chronic Adult Neuromuscular Diseases - Fit4MedRob-Chronic MND Project

Charcot-Marie-Tooth Disease (CMT) Biological Sample Collection for IPSC Generation and Biobanking

Evaluate the Safety and Potential Efficacy of Human Wharton's Jelly-derived Mesenchymal Stem Cells With Charcot-Marie-Tooth Disease Type 1E

Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease